Functional Movement Disorder and Parkinson’s Disease Comorbidity: A Case Report
Case Presentation A 22-year-old male patient presented to the emergency room of hospital with chief complaints of restlessness, an intolerable urge to pace around, suspiciousness, and sleep disturbances in the form of late-onset and midnight awakenings for four days. Medical History Family History Clinical Exam Treatment Clinical Outcome Careful observation, interviews, and periodic mental status […]
Ultra-Long-Acting Oral Antipsychotic for Treatment of Schizophrenia
Conference – American Society of Clinical Psychopharmacology (ASCP) 2021 (June 1-4, 2021) Date – June 03, 2021 Mode – Virtual A new phase II study suggested improved quality of life and treatment adherence in schizophrenic patients with a novel, ultra-long-acting formulation of risperidone (LYN-005). The study comprised of 32 schizophrenia patients received immediate-release (IR) risperidone […]
Ultra-Long-Acting Oral Antipsychotic for Treatment of Schizophrenia
A new phase II study suggested improved quality of life and treatment adherence in schizophrenic patients with a novel, ultra-long-acting formulation of risperidone (LYN-005). The study comprised of 32 schizophrenia patients received immediate-release (IR) risperidone 2 mg or 4 mg and were randomized to either of the four groups, IR risperidone-matched placebo and LYN-005 at […]